AI-Driven Drug Discovery Offers Hope for Rett Syndrome Treatment
AI-driven drug discovery shows promise for Rett syndrome treatment. Vorinostat may offer new hope for affected patients. 🧬💊
July 22, 2025
Follow us
latest articles
Discover the newest research about AI innovations in 🧬 Rare Diseases.
An academic evaluation of ChatGpt’s ability and accuracy in creating patient education resources for rare cardiovascular diseases.
ChatGPT’s accuracy in rare cardiovascular disease education is limited; expert review shows redundancy and incomplete answers. 📉💔
July 19, 2025
Artificial intelligence for diagnosing rare bone diseases: a global survey of healthcare professionals.
AI in Rare Bone Disease Diagnosis: 91% of healthcare professionals value imaging! 🤖📊 Concerns about AI errors persist.
July 17, 2025
Artificial intelligence applications in rare and intractable diseases: Advances, challenges, and future directions.
AI transforms rare disease diagnosis and treatment, addressing 3.5%-5.9% of global cases. Key advancements and challenges discussed. 🤖💊
June 10, 2025
Letter to the Editor on “Artificial Intelligence Based Augmented Reality Navigation in Minimally Invasive Partial Nephrectomy”.
Exploring AI in minimally invasive nephrectomy: insights from Guo Q’s letter on augmented reality navigation. 🤖🔍
June 7, 2025
AI Model Predicts Pediatric Brain Cancer Relapse with High Accuracy
AI predicts pediatric brain cancer relapse with 75-89% accuracy, improving care for children with gliomas. 🧠📈
May 12, 2025
AI Model Trained on NHS Data to Predict Health Outcomes
AI model Foresight uses NHS data to predict health outcomes, aiming for personalized care and early intervention. 📊🤖
May 11, 2025
BioStruct-Africa’s capacity building workshops as a model for advancing the emerging community of structural biologists in Africa.
BioStruct-Africa’s workshops enhance structural biology skills in Africa, utilizing AI tools like AlphaFold for disease research. 🌍🔬
April 23, 2025
Revolutionizing Drug Delivery: The Impact of Advanced Materials Science and Technology on Precision Medicine.
Recent advancements in materials science are transforming drug delivery systems, enhancing precision medicine. 🧬💊 Explore nanocarriers, hydrogels, and AI integration.
March 27, 2025
Does the hepatologist still need to rely on aminotransferases in clinical practice? A reappraisal of the role of a classic biomarker in the diagnosis and clinical management of chronic liver diseases.
Aminotransferases, especially ALT, remain crucial in diagnosing chronic liver diseases. New insights suggest refining diagnostic strategies for better outcomes. 🩺🔍
March 17, 2025